Role of zinc and α2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma

British Journal of Cancer

Volumn 79, Issue 2, 1999, Pages 244-250

  Mocchegiani, E ^a,c   Ciavattini, A ^b   Santarelli, L ^a   Tibaldi, A ^a   Muzzioli, M ^a   Bonazzi, P ^b   Giacconi, R ^a   Fabris, N ^a   Garzetti, G G ^b  

^a Inst Natl Res Centres on A   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c INRCA   (Italy)

Author keywords

Cancer; Interleukin 2; Natural killer activity; Soluble interleukin 2 receptor; Thymulin; Zinc; 2 macroglobulin

Indexed keywords

ALPHA 2 MACROGLOBULIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; THYMULIN; ZINC;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOCRINE FUNCTION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; THYMUS FUNCTION; UTERINE CERVIX CARCINOMA; ZINC BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CELLULAR IMMUNITY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ADULT; ALPHA-MACROGLOBULINS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-2; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; THYMIC FACTOR, CIRCULATING; UTERINE CERVICAL NEOPLASMS; ZINC;

EID: 0032622340     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690040     Document Type: Article

References (54)

1. Bach JF, Dardenne M, Pleau JM and Bach MA (1975) Isolation, biochemical characteristics and biological activity of a circulating thymic hormone in the mouse and in the human. Ann NY Acad Sci USA 249: 186-193
2. Bardos P and Bach JF (1982) Modulation of mouse natural killer cell activity by the serum thymic factor. Scand J Immunol 12: 321-325
3. Bontkes HJ, de Gruijl TD, Walboomers JM, van den Muysemberg AJ, Gunther AW, Scheper RJ, Mejier CJ and Kummer JA (1997) Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions. Br J Cancer 76: 1353-1360
4. Bremner I and May PM (1989) Systemic interaction of zinc. In Zinc in Human Biology. Mills CF (ed.), pp. 95-108. Springer-Verlag: London
5. Broder S and Negson M (1982) The interrelationship between cancer and immune deficiency. In Cancer the Young. Levin AS (ed.), pp. 29-41. Publishing USA: New York
6. Burnet FM (1971) Immunological surveillance in neoplasia. Transplant Rev 7: 3-13
7. Chandra RK (1984) Excessive intake of zinc impairs immune response. J Am Med Assoc 252: 1443-1446
8. Chandra RK (1985) Trace elements regulation and immunity and infection. J Am Coll Nutr 4: 5-16
9. Chu CT, Howard GC, Misra UK and Pizzo SV (1994) α-2 macroglobulin: a sensor of proteolysis. Ann NY Acad Sci USA 737: 291-307
10. Csermely P, Szarme M, Resch K and Somogy J (1988) Zinc can increase the activity of protein kinase C and contributes to its binding to plasma membranes in T lymphocytes. J Biochem Chem 263: 6487-6490
11. Cunningham-Rundles S, Bockman RS, Lin A, Giardina PV, Hilgartner MW, Caldwell-Brown D and Carter DM (1990) Physiological and pharmacological effects of zinc on immune response. Ann NY Acad Sci USA 587: 113-118
12. Dardenne M, Pleau JM, Nabama B, Lefancier P, Denien M, Choay J and Bach JF (1982) Contribution of zinc and other metals to the biological activity of the serum thymic factor. Proc Natl Acad Sci USA 79: 5370-5373
13. Dilman VM (1977) Metabolic immunodepression which increases the risk of cancer. Lancet ii: 1207-1210
14. Dinarello CA (1984) Interleukin 1. Rev Infect Dis 6: 51-94
15. Driessen C, Hirv K and Kirchner H (1994) Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokines Cytokines Res 13: 15-20
16. Enghlid JJ, Salvesen G, Brew K and Nagase H (1989) Interaction of human rheumatoid synovial collagenase (matrix metalloproteinase 1) and stromelysin (metalloproteinase 3) with human α-2 macroglobulin and chicken ovostatin. Binding kinetics and identification of matrix metalloproteinase cleavage sites. J Biol Chem 264: 8779-8785
17. Fabris N and Mocchegiani E (1995) Zinc, human diseases and aging. A review. Aging Clin Exp Res 7: 77-93
18. Fernandez FJ and Khan H (1971) Clinical methods for atomic absorption spectroscopy. Clin Chem News Lett 3: 24-28
19. Garofalo JA, Strong E, Cunningham-Rundles S, Erlandson E, Mendez-Botet C, Schawartz M and Good RA (1979) Serum zinc in patients with epidermial cancer of the head and neck. Fed Proc 38: 713-718
20. Garzetti GG, Ciavaltini A, Lucarini G, Goteri G, De Nictolis M and Biagini G (1996) Microinvasive cenvical carcinoma and cervical intraepithelial neoplasia: biologic significance and clinical implications of 72-kDa metalloproteinase immunostaining. Gynecol Oncol 61: 197-203
21. Gastinel LN, Dardenne M, Pleau JM and Bach JF (1984) Studies on the zinc binding site to the serum hymic factor. Biochim Biophys Acta 797: 147-155
22. Getting PGW and Crews BC (1994) Binding of epidermal growth factor to human α-2 macroglobulin. Significance for cytokines α-2 macroglobulin interactions. Ann NY Acad Sci USA 737: 383-398
23. Giroux EL (1975) Determination of zinc distribution between albumin and α-2 macroglobulin in human serum. Biochem Med 12: 258-266
24. Goldstein AL (1984) Thymic Hormones and Lymphokines. Plenum Press: New York
25. Gooding R, Riches P, Dadian G and Gore M (1995) Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2. Br J Cancer 72: 452-455
26. Gorodetsky R, Fuks Z, Sulkes A, Ginsburg H and Wesheler Z (1985) Correlation of erythrocyte and plasma levels of zinc, copper and iron with evidence of metastatic spread in cancer patients. Cancer 55: 779-786
27. Grigsby PW (1996) Stage IB1 vs IB2 carcinoma of the cervix: should the new FIGO staging system define therapy. Gynaecol Oncol 62: 135-136
28. Hamoudi AB, Newton Jr WA, Mancer R and Penn GD (1982) Thymic changes in histiocitosis. Am J Clin Pathol 77: 169-172
29. Henney CS, Kuribayashi K, Kern DE and Gills S (1981) Interleukin-2 augments natural killer cell activity. Nature 291: 335-340
30. Kahari VM and Saarialho-Kere U (1997) Matrix metalloteinase in skin. A review. Exp Dermatol 6: 199-213
31. James K (1990) Interactions between cytokines and α-2 macroglobulin. Immunol Today 11: 163-166
32. Mackiewicz A, Kushner I and Baumann H (1993) Acute Phase Proteins: Molecular Biology, Biochemistry, Clinical Application. CRC Press: Boca Raton, FL
33. Matoska J, Wahlstrom T, Vaheri A, Bizik J and Grofova M (1988) Tumour associated α-2 macroglobulin in human melanoma. Int J Cancer 41: 359-363
34. Miller GG and Stritlmatter WJ (1992) Identification of human T-cells that require zinc for the growth. Scand J Immunol 36: 269-277
35. Mocchegiani E, Cacciatore L, Talarico M, Lingetti M and Fabris N (1990) Recovery of low thymic hormone levels in cancer patients by lysine-arginine combination. Int J Immunopharmacol 12: 365-371
36. Mocchegiani E, Paolucci P, Granchi D, Cavallazzi L, Santarelli L and Fabris N (1994) Plasma zinc level and thymic hormone activity in young cancer patients. Blood 83: 749-757
37. Mocchegiani E, Verbanac D, Santarelli L, Tibaldi A, Muzzioli M, Radosevic-Stasic B and Milin C (1997) Zinc and metallothioneins on cellular immune effectiveness during liver regeneration in young and old mice. Life Sci 61: 1125-1145
38. Muzzioli M, Mocchegiani E, Bressani N, Bevilacqua P and Fabris N (1992) In vitro restoration by thymulin of NK activity of cells from old mice. Int J Immunopharmacol 14: 57-61
39. Ogata K, Tamura H, Yokose N, An E, Dan K, Hamaguchi H, Sakamaki H, Onozawa Y, Clark SC and Nomura T (1995) Effects of interleukin 12 on natural killer cell cytotoxicity and the production of interferon gamma and tumour necrosis factor-alfa in patients with myelodyspastic syndromes. J Haematol 90: 15-21
40. Park TK and Kim SN (1989) Cell-mediated immunity in patients with invasive carcinoma of the cervix. Yonsei Med J 30: 164-172
41. Pavlidis NA, Bairaktari E, Kalef-Ezra J, Nicolaides C, Seferiadis C and Fountzilas G (1995) Serum soluble interleukin-2 receptors in epithelial ovarian cancer patients. Int J Biol Markers 10: 75-80
42. Pleau JM, Dardenne M, Blanot B, Bricas E and Bach JF (1979) Antagonist analogues of serum thymic factor FTS interacting with the FTS cellular receptor. Immunol Lett 1: 179-184
43. 51 Cr release assay. J Immunol Method 155: 9-24
44. Rani S, Vaidya MC and Rani K (1992) Role of cell growth factor (interleukin-2) and its receptors in carcinoma cervix patients. J Steroid Biochem Mol Biol 41: 837-839
45. Robertson MJ and Ritz J (1990) Biology and clinical relevance of human natural killer cells. Blood 12: 2421-2438
46. Rubin LA, Jay G and Nelsen DL (1986) The released interleukin-2 receptors bind interleukin-2 efficiently. J Immunol 137: 3841-3844
47. Savino W, Huang PC, Corrigan A, Berrih S and Dardenne M (1984) Thymic hormone-containing cells. V. Immunohistological detection of metallothionein within the cells bearing thymulin (a zinc-containing hormone) in human and mouse thymuses. J Histochem Cytochem 32: 942-946
48. Seki S, Abo T, Sugiura K, Otheki T, Kobata T, Yagita H, Okumura K, Rikiishi H, Masuda T and Kumagai K (1991) Reciprocal T-cell response in the liver and in the thymus of mice injected with syngenic tumour cells. Cell Immunol 137: 46-54
49. Shiffman MH and Brinton LA (1995) The epidemiology of cervical carcinogenesis. Cancer 76: 1888-1901
50. Stetler-Stevenson WG, Liotta LA and Kleiner Jr DE (1993) Extracellular matrix 6: role of matrix metalloproteinase in tumour invasion and metastasis. FASEB J 7: 1434-1441
51. Tanaka Y, Shiozawa S, Moromoto I and Fujita T (1990) Role of zinc in interleukin-2 (IL-2)-mediated T-cell activation. Scand J Immunol 31: 547-552
52. Trinchieri G and Scott P (1994) The role of interleukin 12 in the immune response, diseases and therapy. Immunol Today 15: 460-463
53. Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM (1996) Suppression of TNF-alfa-induced apoptosis by NF-kB. Science 274: 787-789
54. Wasik K, Vonderheid EC, Bigler RD, Marti R, Lessin SR, Polanski M and Kadin ME (1996) Increased serum concentration of the soluble interleukin-2 soluble receptor in cutaneous T-cell lymphoma. Arch Dermatol 132: 42-47